Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma

WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours

(2018) F. Sahm et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications

(2018) Yang Jiao et al.   BIOCHEMISTRY-MOSCOW

CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma

(2017) GEORGIA KOULERMOU et al.   JOURNAL OF GENETICS

The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?

(2017) Kira Marie Voß et al.   JOURNAL OF NEURO-ONCOLOGY

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

(2017) Felix Sahm et al.   LANCET ONCOLOGY

MultiQC: summarize analysis results for multiple tools and samples in a single report

(2016) Philip Ewels et al.   BIOINFORMATICS

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia

(2016) Pierre Hirsch et al.   Nature Communications

Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis

(2015) M. Dal Molin et al.   CLINICAL CANCER RESEARCH

PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss

(2015) Matthieu Peyre et al.   Oncotarget

Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas

(2014) Min Soo Kim et al.   JOURNAL OF NEUROSURGERY

Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression

(2014) Gang Cheng et al.   MEDICAL ONCOLOGY

Molecular subtyping of bladder cancer using Kohonen self-organizing maps

(2014) Edyta M. Borkowska et al.   Cancer Medicine

Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14 ARF and RARβ Signaling

(2013) Christina Dahl et al.   MOLECULAR CANCER RESEARCH

Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas

(2012) Andrew Yew et al.   JOURNAL OF CLINICAL NEUROSCIENCE

EGFR Soluble Isoforms and Their Transcripts Are Expressed in Meningiomas

(2012) Angélique Guillaudeau et al.   PLoS One

ContEst: estimating cross-contamination of human samples in next-generation sequencing data

(2011) Kristian Cibulskis et al.   BIOINFORMATICS

Genetic and molecular alterations in meningiomas

(2011) George A. Alexiou et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil

(2011) Renato M. Bakos et al.   EXPERIMENTAL DERMATOLOGY

Update on Meningiomas

(2011) S. Saraf et al.   ONCOLOGIST

Pathological classification and molecular genetics of meningiomas

(2010) Christian Mawrin et al.   JOURNAL OF NEURO-ONCOLOGY

Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors

(2010) Majid Kheirollahi et al.   MEDICAL ONCOLOGY

Genomic Landscape of Meningiomas

(2009) Yohan Lee et al.   BRAIN PATHOLOGY

WHO grade II and III meningiomas: a study of prognostic factors

(2009) Anne Durand et al.   JOURNAL OF NEURO-ONCOLOGY